No current affiliations available for this person. The person is no longer active at the university.

Publications

Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report. Lohmann L, Glaser F, Möddel G, Lünemann JD, Wiendl H, Klotz L (2022) In: BMC Neurology, 22(1), 185-185. doi:10.1186/s12883-022-02698-y Research article (journal) \| Peer reviewed \| Published
KCa channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549) Glaser F., Hundehege P., Bulk E., Todesca L.M., Schimmelpfennig S., Nass E., Budde T., Meuth S.G., Schwab A. (2021) In: Scientific Reports, 11(1), 18330. doi:10.1038/s41598-021-97406-0 Research article (journal) \| Peer reviewed \| Published

Doctorates

Effekte einer Kombinationstherapie mit dem Tyrosinkinase-Inhibitor Erlotinib und dem K Ca 3.1-Kanal-Blocker Senicapoc auf A549-3R-NSCLC-Zellen
Candidate: Glaser, Felix | Supervisors: Schwab, Albrecht; Meuth, Sven | Reviewers: Schwab, Albrecht; Meuth, Sven
Period of time: 19/08/2016 - 21/09/2018
Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster